LH
GILD icon

Lebenthal Holdings’s Gilead Sciences GILD Stock Holding History

Lebenthal Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$4.8M Buy
57,497
+6,039
+12% +$536K 0.6% 45
2016
Q1 		$4.73M Buy
51,458
+11,192
+28% +$1.01M 0.83% 20
2015
Q4 		$4.07M Buy
40,266
+4,255
+12% +$443K 0.96% 17
2015
Q3 		$3.54M Buy
36,011
+1,366
+4% +$152K 0.81% 17
2015
Q2 		$4.02M Buy
34,645
+26,706
+336% +$2.92M 0.82% 18
2015
Q1 		$779K Buy
7,939
+286
+4% +$29K 0.18% 170
2014
Q4 		$721K Buy
+7,653
New +$792K 0.32% 92

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lebenthal Holdings's GILD Position: Q2 2016 in Review

Lebenthal Holdings increased its Gilead Sciences (GILD) stake by 12% in Q2 2016, buying an estimated $536K and bringing the position to 57,497 shares worth $4.8M. The position accounts for 0.6% of the portfolio, ranked #45.

Lebenthal Holdings first reported a position in GILD in Q4 2014 and has held it in 7 quarters since. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Lebenthal Holdings held 57,497 shares of Gilead Sciences worth $4.8M as of Q2 2016.
  • Lebenthal Holdings bought 6,039 Gilead Sciences shares in Q2 2016, an estimated $536K.
  • Gilead Sciences made up 0.6% of Lebenthal Holdings's portfolio in Q2 2016, its #45 holding.
  • Lebenthal Holdings first reported a position in Gilead Sciences in Q4 2014 and has held it in 7 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.